ISIN | LU1540961247 |
---|---|
Valor Number | 35006956 |
Bloomberg Global ID | |
Fund Name | HBM Global Healthcare Fund P USD Cap |
Fund Provider |
HBM Partners AG
Zug, Schweiz Phone: +41 43 888 71 71 E-Mail: investorrelations@hbmpartners.com Web: www.hbmpartners.com |
Fund Provider | HBM Partners AG |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | FundPartner Solutions (Suisse) S.A. |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long-term capital gains, by pursuing a long/short strategy in the "healthcare" market. The goal is to generate a value trend that exceeds the performance of the SOFR (the “Benchmark”). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 282.18 USD | 01.08.2024 |
---|---|---|
Previous Price * | 278.03 USD | 31.07.2024 |
52 Week High * | 282.69 USD | 16.07.2024 |
52 Week Low * | 210.28 USD | 27.10.2023 |
NAV * | 282.18 USD | 01.08.2024 |
Issue Price * | 282.18 USD | 01.08.2024 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 19,012,709 | |
Unit/Share Assets *** | 16,459,860 | |
Trading Information SIX |
YTD Performance | +13.57% |
29.12.2023 - 01.08.2024
29.12.2023 01.08.2024 |
---|---|---|
YTD Performance (in CHF) | +17.86% |
29.12.2023 - 01.08.2024
29.12.2023 01.08.2024 |
1 month | +3.85% |
01.07.2024 - 01.08.2024
01.07.2024 01.08.2024 |
3 months | +7.48% |
02.05.2024 - 01.08.2024
02.05.2024 01.08.2024 |
6 months | +9.12% |
01.02.2024 - 01.08.2024
01.02.2024 01.08.2024 |
1 year | +16.79% |
01.08.2023 - 01.08.2024
01.08.2023 01.08.2024 |
2 years | +17.83% |
03.08.2022 - 01.08.2024
03.08.2022 01.08.2024 |
3 years | +3.29% |
04.08.2021 - 01.08.2024
04.08.2021 01.08.2024 |
5 years | +51.80% |
07.08.2019 - 01.08.2024
07.08.2019 01.08.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 9.56% | |
---|---|---|
Novo Nordisk A/S Class B | 6.58% | |
UnitedHealth Group Inc | 6.51% | |
McKesson Corp | 5.84% | |
AbbVie Inc | 4.76% | |
Stryker Corp | 4.73% | |
DexCom Inc | 3.46% | |
UCB SA | 3.30% | |
The Cooper Companies Inc | 3.30% | |
Exact Sciences Corp | 3.29% | |
Last data update | 30.06.2024 |
TER | 0.0165% |
---|---|
TER date | 31.01.2018 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.20% |
Ongoing Charges *** | 1.80% |
SRRI ***
|
|
SRRI date *** | 30.06.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |